[Lys5,MeLeu9,Nle10]-NKA(4-10) is a modified tachykinin fragment incorporating residue substitutions that modulate folding and binding behavior. Hydrophobic and basic groups influence structural orientation. The sequence supports motif-specific mapping. Researchers use it to explore structure–function variation within tachykinin analogs.
![[Lys5,MeLeu9,Nle10]-NKA(4-10)(CAS 137565-28-7)](https://img.creative-peptides.com/structure/137565-28-72d.png)
CAT No: R0867
CAS No:137565-28-7
Synonyms/Alias:137565-28-7;L-Asp-L-Lys-L-Phe-L-Val-Gly-N-methyl-L-Leu-L-Nle-NH2;[Lys5,MeLeu9,Nle10]-NKA(4-10);(3S)-3-amino-4-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-methylamino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutanoic acid;DKFVGLX;AKOS024457493;(3S,6S,9S,12S,18S,21S)-3-Amino-6-(4-aminobutyl)-9-benzyl-21-carbamoyl-18-isobutyl-12-isopropyl-17-methyl-4,7,10,13,16,19-hexaoxo-5,8,11,14,17,20-hexaazapentacosan-1-oic acid;DA-69329;TS-10495;[Lys5,MeLeu9,Nle10] -NKA(4-10);G78711;(3S)-3-amino-3-{[(1S)-5-amino-1-{[(1S)-1-{[(1S)-1-[({[(1S)-1-{[(1S)-1-carbamoylpentyl]carbamoyl}-3-methylbutyl](methyl)carbamoyl}methyl)carbamoyl]-2-methylpropyl]carbamoyl}-2-phenylethyl]carbamoyl}pentyl]carbamoyl}propanoic acid;
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Emu oil in combination with other active ingredients for treating skin imperfections
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More